BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34964410)

  • 1. Ultrasound-sensitive siRNA-loaded nanobubbles fabrication and antagonism in drug resistance for NSCLC.
    Su C; Ren X; Yang F; Li B; Wu H; Li H; Nie F
    Drug Deliv; 2022 Dec; 29(1):99-110. PubMed ID: 34964410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-mediated mesoporous silica nanoparticles loaded with PDLIM5 siRNA inhibit gefitinib resistance in NSCLC cells by attenuating EMT.
    Wu H; Lv WH; Zhu YY; Jia YY; Nie F
    Eur J Pharm Sci; 2023 Mar; 182():106372. PubMed ID: 36621614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the relationship between autophagy and Gefitinib resistance in NSCLC by silencing PDLIM5 using ultrasound-targeted microbubble destruction technology.
    Zhang Y; Lv W; Li H; Dong T; Wu H; Su C; Shu H; Nie F
    Cancer Cell Int; 2022 Sep; 22(1):293. PubMed ID: 36154921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction.
    Cai W; Lv W; Feng Y; Yang H; Zhang Y; Yang G; Duan Y; Wang J
    Int J Nanomedicine; 2018; 13():6791-6807. PubMed ID: 30425489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of nanobubbles carrying androgen receptor siRNA and their inhibitory effects on androgen-independent prostate cancer when combined with ultrasonic irradiation.
    Wang L; Zhang M; Tan K; Guo Y; Tong H; Fan X; Fang K; Li R
    PLoS One; 2014; 9(5):e96586. PubMed ID: 24798477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient siRNA Delivery Using Novel Cell-Penetrating Peptide-siRNA Conjugate-Loaded Nanobubbles and Ultrasound.
    Xie X; Lin W; Li M; Yang Y; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
    Ultrasound Med Biol; 2016 Jun; 42(6):1362-74. PubMed ID: 27012462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells.
    Akbaba H; Erel-Akbaba G; Kotmakçı M; Başpınar Y
    Pharm Res; 2020 Aug; 37(8):165. PubMed ID: 32761250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy.
    Chen D; Zhang P; Li M; Li C; Lu X; Sun Y; Sun K
    Drug Deliv; 2022 Dec; 29(1):574-587. PubMed ID: 35156491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of RNA interference combined with ultrasonic irradiation and SonoVue microbubbles on expression of STAT3 gene in keratinocytes of psoriatic lesions.
    Ran LW; Wang H; Lan D; Jia HX; Yu SS
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):279-285. PubMed ID: 28397054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
    Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
    Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles.
    Nittayacharn P; Yuan HX; Hernandez C; Bielecki P; Zhou H; Exner AA
    J Pharm Sci; 2019 Sep; 108(9):3091-3098. PubMed ID: 31095958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction sensitive nanocarriers mPEG-g-γ-PGA/SSBPEI@siRNA for effective targeted delivery of survivin siRNA against NSCLC.
    Chen L; Wang S; Liu Q; Zhang Z; Lin S; Zheng Q; Cheng M; Li Y; Cheng C
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111105. PubMed ID: 32417465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas.
    Yin T; Wang P; Li J; Zheng R; Zheng B; Cheng D; Li R; Lai J; Shuai X
    Biomaterials; 2013 Jun; 34(18):4532-43. PubMed ID: 23522375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
    Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
    Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nanobubbles in low-frequency ultrasound-mediated gene transfection and growth inhibition of hepatocellular carcinoma cells.
    Wu B; Qiao Q; Han X; Jing H; Zhang H; Liang H; Cheng W
    Tumour Biol; 2016 Sep; 37(9):12113-12121. PubMed ID: 27216880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Feasibility of integrating tumor therapy with therapeutic effect evaluation using siRNA-loaded microbubbles].
    Li S; Yin T; Li J; Zheng B; Qiu C; Wang P
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):874-8. PubMed ID: 26111688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑378 in combination with ultrasonic irradiation and SonoVue microbubbles transfection inhibits hepatoma cell growth.
    Wang J; Li Y; Ma Q; Huang J
    Mol Med Rep; 2020 Jun; 21(6):2493-2501. PubMed ID: 32236628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-Mediated PLGA-PEI Nanobubbles Carrying STAT6 SiRNA Enhances NSCLC Treatment via Repolarizing Tumor-associated Macrophages from M2 to M1 Phenotypes.
    Shu H; Lv W; Ren ZJ; Li H; Dong T; Zhang Y; Nie F
    Curr Drug Deliv; 2023 Jul; ():. PubMed ID: 37491853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.